Guardant Health (GH) Tops Q1 EPS by 10c, Revs Beat; Withdraws Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. ARM
3. FIS
4. BROS
5. QCOM
6. EXPE
7. FSLY
8. CPAY
9. FICO
10. PAYC

Go back to Guardant Health (GH) Tops Q1 EPS by 10c, Revs Beat; Withdraws Guidance

Guardant Health Reports First Quarter 2020 Financial Results

May 7, 2020 4:03 PM EDT

REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2020.

Recent Highlights

Revenue of $67.5 million for the first quarter of 2020, representing an 84% increase over the corresponding period of 2019 Reported 15,257 tests to clinical customers and 5,266 tests to biopharmaceutical customers in the first quarter of 2020, representing increases of 60% and 40%,... More